IHC Single Slide Staining without Reporting at Chughtai Lab

Introduction to IHC Single Slide Staining without Reporting at Chughtai Lab

Immunohistochemistry (IHC) is an indispensable diagnostic technique in modern pathology that combines anatomical, immunological, and biochemical methods to identify specific cellular components within tissue samples. IHC single slide staining without reporting at Chughtai Lab in Pakistan offers a specialized technical service designed for patients, clinical researchers, and referring pathologists who require high-quality, automated staining of specific tissue antigens but prefer to have the final diagnostic interpretation performed by their own designated pathologist or an external specialist. This service is particularly valuable when seeking second opinions, conducting specialized research, or utilizing a specific diagnostic panel that may not be locally available. By leveraging the advanced laboratory infrastructure of Chughtai Lab, healthcare providers across Pakistan can access precise, reproducible, and standardized staining protocols for a wide array of diagnostic, prognostic, and predictive biomarkers.

Understanding the Clinical Importance and Diagnostic Value

The primary clinical utility of immunohistochemistry lies in its ability to detect the presence, localization, and abundance of specific proteins within the context of tissue architecture. Unlike routine Hematoxylin and Eosin (H&E) staining, which highlights general cellular morphology, IHC uses highly specific monoclonal or polyclonal antibodies to target unique cellular antigens. When these antibodies bind to their target proteins, a chemical reaction mediated by enzymes like horseradish peroxidase (HRP) produces a visible color change under a light microscope. This allows pathologists to identify the exact lineage of poorly differentiated tumor cells, determine the primary site of metastatic malignancies, and assess therapeutic targets. The “without reporting” option ensures that the technical phase of this complex process is performed under rigorous quality control standards at Chughtai Lab, while the clinical interpretation remains in the hands of the patient’s primary medical team.

Clinical Procedure: What to Expect

Patient Preparation and Specimen Submission

Because IHC single slide staining is a laboratory-based analysis performed on pre-existing tissue samples, there is no direct physical preparation required from the patient. However, ensuring the integrity of the specimen is critical for accurate staining results. Patients or referring clinics must adhere to the following guidelines:

• Provide the original Formalin-Fixed Paraffin-Embedded (FFPE) tissue block or high-quality, unstained tissue sections mounted on charged (adhesive) glass slides. Charged slides are mandatory to prevent the tissue from detaching during the harsh antigen retrieval process.
• Ensure that the tissue has been properly fixed in 10% neutral buffered formalin for an optimal duration of 6 to 48 hours. Under-fixation or over-fixation can severely compromise antigen preservation.
• Submit a copy of the original histopathology report (H&E stained slide report) and the specific antibody request form signed by the referring pathologist.
• Maintain appropriate temperature control during the transport of paraffin blocks or slides, avoiding exposure to extreme heat or direct sunlight, which can melt the wax and degrade the proteins.

During the Laboratory Procedure

Once the specimen is received at the histopathology department of Chughtai Lab, it undergoes a highly standardized, automated technical process:

• Slide Cutting: If a paraffin block is submitted, expert histotechnologists cut ultra-thin sections (typically 3 to 4 microns thick) using a precision microtome and mount them onto positively charged slides.
• Deparaffinization and Rehydration: The slides are heated and treated with clearing agents like xylene to remove the paraffin wax, followed by sequential washes in descending concentrations of ethanol to rehydrate the tissue.
• Antigen Retrieval: To expose epitope sites that may have been masked during formalin fixation, the slides undergo Heat-Induced Epitope Retrieval (HIER) using specialized buffer solutions (such as citrate or EDTA buffers) under controlled temperature and pressure, or Proteolytic-Induced Epitope Retrieval (PIER).
• Primary Antibody Incubation: The specific primary antibody requested (e.g., ER, PR, HER2, Ki-67, CD20) is applied to the slide, allowing it to bind specifically to the target antigen.
• Detection and Visualization: A secondary antibody conjugated with an enzyme-polymer complex is applied, followed by a chromogen substrate (such as 3,3′-Diaminobenzidine or DAB). This reaction produces a highly visible brown or red precipitate at the site of antigen localization.
• Counterstaining and Mounting: The slide is counterstained with hematoxylin to visualize cell nuclei, dehydrated, cleared, and sealed with a coverslip to protect the stained tissue for long-term storage and microscopic evaluation.

When is IHC Single Slide Staining without Reporting Performed?

Subtyping of Poorly Differentiated Malignancies

When a biopsy specimen shows highly abnormal, undifferentiated cells on standard H&E staining, it can be impossible to determine whether the tumor is a carcinoma, sarcoma, lymphoma, or melanoma. Physicians request specific IHC staining slides, such as Cytokeratins, Vimentin, CD45, or S100, to establish the cellular lineage and guide the appropriate therapeutic pathway.

Identification of Metastatic Tumors of Unknown Primary Origin

In cases where a patient presents with metastatic disease (for example, a tumor in the liver, lung, or bone) but the primary site is unknown, specific IHC markers are utilized to trace the tissue of origin. Staining for organ-specific markers like TTF-1 (lung/thyroid), CDX2 (gastrointestinal), or PSA (prostate) on a single slide helps narrow down the primary tumor site.

Assessment of Prognostic and Predictive Breast Cancer Markers

For patients diagnosed with breast carcinoma, determining the expression of Estrogen Receptor (ER), Progesterone Receptor (PR), and Human Epidermal Growth Factor Receptor 2 (HER2) is standard clinical practice. Staining these markers on individual slides allows oncologists to predict tumor behavior and determine eligibility for targeted endocrine or anti-HER2 therapies.

Evaluation of Tumor Proliferation Rates

The Ki-67 antigen is a cellular marker for proliferation. Measuring the percentage of Ki-67 positive tumor nuclei is crucial for grading various malignancies, particularly neuroendocrine tumors and lymphomas. A high Ki-67 index indicates rapid tumor growth, which influences the aggressiveness of the treatment regimen.

Lineage Determination in Hematolymphoid Neoplasms

When lymphoma is suspected, distinguishing between B-cell and T-cell lineages is essential for correct classification and treatment selection. Single slide staining for markers like CD20 (B-cells) and CD3 (T-cells) provides clear visual evidence of the prevailing cell population within the lymphoid tissue.

What Does IHC Single Slide Staining Detect?

Immunohistochemical staining is capable of detecting a vast array of specific proteins, receptors, and cellular markers. Depending on the specific antibody requested for the slide, this technical procedure can detect:

• Estrogen Receptors (ER) within the nuclei of breast epithelial cells.
• Progesterone Receptors (PR) indicating hormone sensitivity in uterine or breast tissues.
• HER2/neu protein overexpression on the cell membrane of breast or gastric cancer cells.
• Ki-67 protein expression indicating the active phases of the cell cycle.
• Cytokeratin (CK) cocktails confirming the epithelial nature of a lesion.
• CD20 antigen expression on the surface of mature B-lymphocytes.
• CD3 antigen expression on the surface of T-lymphocytes.
• S100 protein expression in melanocytes, neural tissues, and Langerhans cells.
• Melan-A expression confirming melanocytic differentiation in suspected melanomas.
• Thyroid Transcription Factor-1 (TTF-1) indicating lung or thyroid lineage.
• CDX2 protein expression indicating intestinal epithelial differentiation.
• Prostate-Specific Antigen (PSA) in prostatic glandular tissue.
• Synaptophysin expression in neuroendocrine cells and tumors.
• Chromogranin A expression in secretory granules of neuroendocrine neoplasms.
• Desmin expression in smooth and skeletal muscle cells and related tumors.
• Vimentin expression in mesenchymal cells and sarcomas.
• CD45 (Leukocyte Common Antigen) confirming hematolymphoid origin.
• p53 tumor suppressor protein accumulation indicating TP53 gene mutations.
• GATA3 expression in breast and urothelial carcinomas.
• Calretinin expression in mesothelial cells, aiding in the diagnosis of mesothelioma.
• CD30 expression in Reed-Sternberg cells of Hodgkin lymphoma.
• CD15 expression in Hodgkin lymphoma and certain epithelial cancers.
• BCL2 protein expression, useful in distinguishing follicular lymphoma from reactive hyperplasia.
• Cyclin D1 nuclear expression, characteristic of mantle cell lymphoma.
• E-cadherin expression, used to differentiate ductal from lobular breast carcinomas.
• p63 expression in basal and myoepithelial cells, helping confirm microinvasion.
• Calponin expression in myoepithelial cells of the breast.
• CD117 (c-kit) expression in gastrointestinal stromal tumors (GIST).
• DOG1 expression in gastrointestinal stromal tumors.
• Smooth Muscle Actin (SMA) expression in myofibroblasts and smooth muscle cells.

Turnaround Time and Report Access at Chughtai Lab

Because this service involves IHC single slide staining without reporting, the turnaround time is significantly shorter than a full histopathological evaluation. Typically, the stained slides are ready for collection within 48 to 72 hours from the time of specimen submission and verification at the Chughtai Lab histopathology department. Patients and referring clinics can track the status of their staining request online through the official Chughtai Lab website or via the Chughtai Lab mobile application. Once the technical staining is complete, the physical slides are carefully packaged and made available for pickup at the designated Chughtai Lab collection center, allowing the patient to deliver them directly to their primary pathologist for expert diagnostic interpretation.

IHC Single Slide Staining Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Estrogen Receptor (ER)	Weak to moderate nuclear staining in normal breast lobular and ductal epithelium.	Strong, diffuse nuclear positivity in luminal-type breast adenocarcinomas.
HER2/neu Protein	No staining or faint, incomplete membrane staining in normal epithelial cells.	Strong, continuous, circumferential membrane staining (Score 3+) in breast or gastric cancers.
Ki-67 Proliferation Index	Low nuclear staining (typically less than 5%) in resting, non-proliferative tissues.	High nuclear staining percentage (e.g., greater than 30%) indicating rapid cellular proliferation.
Cytokeratin (CK) Cocktail	Diffuse cytoplasmic staining in epithelial cells; negative in mesenchymal cells.	Strong cytoplasmic positivity in metastatic carcinoma cells located within lymph nodes or distant organs.
CD20 Antigen	Strong membrane staining in B-lymphocytes within lymphoid follicles.	Diffuse, dense membrane staining in B-cell lymphomas, confirming lineage.
CD3 Antigen	Strong membrane staining in T-lymphocytes within paracortical zones.	Abnormal sheets of CD3-positive cells in T-cell lymphomas or inflammatory infiltrates.
Synaptophysin	Cytoplasmic staining restricted to normal neuroendocrine cells and central nervous system tissue.	Diffuse, strong cytoplasmic positivity in neuroendocrine tumors, carcinoids, or small cell carcinomas.
p63 Protein	Continuous nuclear staining in the basal layer of prostate glands and myoepithelial cells of breast ducts.	Complete absence of staining in invasive prostatic adenocarcinoma or invasive breast carcinoma.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for IHC Single Slide Staining?

• Experienced healthcare professionals and dedicated histotechnologists ensuring technical precision.
• State-of-the-art automated immunohistochemistry staining platforms that minimize manual errors.
• An extensive inventory of high-quality, clinically validated primary antibodies.
• Strict adherence to international quality control and quality assurance protocols.
• Convenient sample submission and slide retrieval at numerous locations across Pakistan.
• Efficient digital tracking of your specimen status via the Chughtai Lab website and mobile app.
• A trusted partner for pathologists and oncology clinics seeking reliable reference laboratory services.
• Commitment to providing rapid, standardized technical processing to support timely clinical decisions.